DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Targacept , Inc. (NASDAQ: TRGT)

2.41 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TRGT $2.41 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.40
Previous Close $2.41
Daily Range $2.34 - $2.43
52-Week Range $2.18 - $4.68
Market Cap $81.4M
P/E Ratio -2.48
Dividend (Yield) $0.00 (0.0%)
Volume 87,010
Average Daily Volume 164,092
Current FY EPS -$1.09

Sector

Healthcare

Industry

Drug Makers

Targacept , Inc. (TRGT) Description

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. Website: http://www.targacept.com/

News & Commentary

Keep an Eye on Biogen, Johnson & Johnson, and Merck Today

Biogen, Johnson & Johnson, and Merck could all make health care headlines this morning. Here’s all the news you need to know.

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastropa

Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Pres

The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead - Press Releases

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blo

Biotech Stock Roundup: Alkermes Drug Fares Well, Targacept Slides on Deal Termination - Analyst Blog

Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog

Why I Am Still Long Targacept After The Reverse Merger Announcement

Targacept Management Increases Urgency And Aims For Q4 Strategic Action

Targacept's (TRGT) CEO Dr. Stephen Hill on Q3 2014 Results - Earnings Call Transcript

Targacept (TRGT) Q3 2014 Results - Earnings Call Webcast

See More TRGT News...

TRGT's Top Competitors

TRGT $2.41 (0.00%)
Current stock: TRGT
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB